KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $743,909,000 | +79.6% | 4,137,189 | +3.6% | 0.04% | +72.7% |
| Q2 2017 | $414,190,000 | +45.7% | 3,995,272 | +10.3% | 0.02% | +37.5% |
| Q1 2017 | $284,287,000 | +186930.9% | 3,621,971 | +106272.1% | 0.02% | – |
| Q4 2016 | $152,000 | -33.6% | 3,405 | -17.2% | 0.00% | – |
| Q3 2016 | $229,000 | +13.9% | 4,112 | +2.2% | 0.00% | – |
| Q2 2016 | $201,000 | +107.2% | 4,022 | +91.9% | 0.00% | – |
| Q1 2016 | $97,000 | +22.8% | 2,096 | +63.4% | 0.00% | – |
| Q4 2015 | $79,000 | +107.9% | 1,283 | +88.1% | 0.00% | – |
| Q3 2015 | $38,000 | -22.4% | 682 | -14.6% | 0.00% | – |
| Q2 2015 | $49,000 | +276.9% | 799 | +258.3% | 0.00% | – |
| Q1 2015 | $13,000 | 0.0% | 223 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | +116.7% | 223 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | – | 223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|